News

#Edwards Lifesciences to get $4.2 billion in cash for sale of critical-care group

Edwards said it plans to use the proceeds from the sale of the business to fund investments for growth, such as in technologies for aortic, mitral, tricuspid and pulmonic patients; and therapeutic areas for interventional heart failure.

If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.